Hydroxocobalamin
Cyanokit (hydroxocobalamin) is a small molecule pharmaceutical. Hydroxocobalamin was first approved as Cyanokit on 2006-12-15. It is used to treat alcoholic neuropathy, diabetic neuropathies, multiple sclerosis, pernicious anemia, and poisoning in the USA. It has been approved in Europe to treat poisoning.
Trade Name | Cyanokit |
---|---|
Common Name | Hydroxocobalamin |
Indication | alcoholic neuropathy, diabetic neuropathies, multiple sclerosis, pernicious anemia, poisoning |
Drug Class |